Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • eiretekk eiretekk Feb 4, 2014 9:03 AM Flag

    Outperform rating - positive feedback on the company's KINECT-2 data. - $23

    Leerink raised its price target for Neurocrine shares to $23 from $18 citing positive feedback on the company's KINECT-2 data. The firm reiterates an Outperform rating on the stock.

 
NBIX
42.55+0.57(+1.36%)May 22 4:00 PMEDT